𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro differentiation and antigenic changes in human melanoma cell lines

✍ Scribed by Ludovico Guarini; Massimo Temponi; Gretchen M. Edwalds; Joseph R. Vita; Paul B. Fisher; Soldano Ferrone

Publisher
Springer-Verlag
Year
1989
Tongue
English
Weight
924 KB
Volume
30
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of tumor-associated antigens
Expression of tumor-associated antigens and kinetic profile of two in vitro human melanoma cell lines
✍ G. Badaracco; A. Corsi; A. Maisto; P. G. Natali; G. Starace; G. Zupi πŸ“‚ Article πŸ“… 1981 πŸ› John Wiley and Sons 🌐 English βš– 490 KB

## Abstract The growth characteristics and the antigenic profile of two human melanoma established cell lines __in vitro__ are reported. The growth curves of the two cell lines show some peculiar features which are also detected in their DNA distribution content. In the late stages of growth, in fa

Hypoxia-induced resistance to doxorubici
Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro
✍ Kirsten Sanna; Einar K. Rofstad πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 581 KB

## Abstract Rodent cell lines can develop resistance to doxorubicin and methotrexate during hypoxic stress. This has so far not been observed in human tumor cell lines. The purpose of our communication is to show that doxorubicin and methotrexate resistance can also develop in human melanoma cells

Detection of tumor-associated antigen in
Detection of tumor-associated antigen in human melanoma cell line supernatants
✍ Elizabeth A. Grimm; Hulbert K. B. Silver; Jack A. Roth; Darwin O. Chee; Rishab K πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 French βš– 477 KB

## Abstract Spent tissue culture medium (CDM‐S) removed from a single cell line of human malignant melanoma grown in serum‐free CDM, contained tumor‐associated antigenic activity. Antibodies to CDM‐S measured by complement fixation were detected in 44% (31/70) melanoma, 55% (15/27) sarcoma, 63% (24